Internal Medicine, Hematology & Oncology · Ponce, PR
NPI
1114961091
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
35 Calle Castillo
Ponce, PR, 00730
Phone (787) 840-1717
Medicare paid, 2024
$35K
1,479 services
Medicare patients, 2024
28
Average age 76
Drug cost, 2024
$3.3M
1,192 prescriptions
Company payments, 2025
$40
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Cangiano was code 99213 (office e&m - established), 47 times for 24 patients. In total Jose A Cangiano billed 1,479 services in 28 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 47 | 24 | $62.94 | $2,958 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 27 | 11 | $0.51 | $13.78 |
| 96361 Intravenous Infusion, Hydration | Office | 17 | 11 | $9.58 | $163 |
By year: 2022 $75K for 4,875 services; 2023 $28K for 1,806 services; 2024 $35K for 1,479 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Cangiano prescribed most often to Medicare patients was Anastrozole, with 360 prescriptions and refills. In total Jose A Cangiano wrote 1,192 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 360 | 481 | 60 | $6,527 |
| Exemestane Generic | 63 | 90 | 12 | $7,732 |
| Letrozole Generic | 37 | 39 | Under 11 | $425 |
| Raloxifene Hcl Generic | 36 | 49 | Under 11 | $1,480 |
| Prednisone Generic | 32 | 32 | 11 | $259 |
| Ondansetron Hcl Generic | 30 | 30 | 14 | $907 |
| Kisqali Ribociclib Succinate | 29 | 29 | Under 11 | $515K |
| Xtandi Enzalutamide | 28 | 28 | Under 11 | $399K |
| Ibrance Palbociclib | 26 | 26 | Under 11 | $415K |
| Tamoxifen Citrate Generic | 23 | 33 | Under 11 | $712 |
| Erleada Apalutamide | 23 | 23 | Under 11 | $339K |
| Bicalutamide Generic | 22 | 24 | Under 11 | $646 |
| Lonsurf Trifluridine/Tipiracil Hcl | 22 | 22 | Under 11 | $182K |
| Ibandronate Sodium Generic | 20 | 24 | Under 11 | $351 |
| Baclofen Generic | 19 | 19 | 16 | $134 |
Brand drugs: 280 claims; generic drugs: 912 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Cangiano $40 ($40 in general payments such as food, travel and fees) from 2 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $40.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.